MOBILE VIEW  | 

HIGHER ALCOHOLS

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Higher alcohols are generally considered to have 3,4, and 5 carbon chains, and are also referred to as "pentanols". Higher alcohols are of a low order of toxicity in an industrial setting. As the carbon chain lengthens, the toxicity decreases. These alcohols are not able to penetrate the skin as readily as smaller molecular weight alcohols; they are less likely to be inhaled.
    B) Toxic exposures may result in CNS depression, hypotension and gastrointestinal irritation. They are mucous membrane irritants.

Specific Substances

    A) Isoamyl Alcohol
    1) 1-Butanol, 3-methyl
    2) Isoamyl alcohol, primary (OSHA)
    3) Isoamylol
    4) Isobutylcarbinol
    5) Isopentanol
    6) Isopentyl alcohol
    7) Molecular Formula: C5-H12-O
    8) CAS 123-51-3
    dl-sec-Isoamyl Alcohol
    1) sec-Isopentyl alcohol
    2) Isopropyl methyl carbinol
    3) 3-Methyl-2-butanol
    4) Molecular Formula: C5-H12-O
    5) CAS 598-75-4
    n-Amyl Alcohol
    1) n-Butyl carbinol
    2) Pentyl alcohol
    3) Molecular Formula: C5-H12-O
    4) CAS 71-4-0
    dl-sec Amyl Alcohol
    1) Methyl propyl carbinol
    2) 2-Pentanol
    3) Molecular Formula: C5-H12-O
    4) CAS 6032-29-7
    1-Propanol
    1) n-propanol
    2) n-propyl alcohol
    3) CAS 71-23-8
    3-Pentanol
    1) Diethyl carbinol
    2) Molecular Formula: C5-H12-O
    3) CAS 584-O2-1
    tert-Amyl Alcohol
    1) 2-Methyl-2-butanol
    2) Dimethyl ethyl carbinol
    3) Ethyl dimethyl carbinol
    4) tert-Pentanol
    5) tert-Pentyl alcohol
    6) Amylene hydrate
    7) Molecular Formula: C5-H12-O
    8) CAS 75-85-4
    n-Butyl Alcohol
    1) 1-Butanol
    2) Butyric or normal primary butyl alcohol
    3) Butyl alcohol
    4) Butyl alcohol, n-
    5) Normal propyl alcohol
    6) Primary butyl alcohol
    7) Propyl carbinol
    8) Molecular Formula: C4-H10-O
    9) CAS 71-36-3
    sec-Butyl Alcohol
    1) 2-Butanol
    2) Butylene hydrate
    3) 2-Hydroxybutane
    4) Methyl ethyl carbinol
    5) Molecular Formula: C4-H10-O
    6) CAS 78-92-2
    tert-Butyl Alcohol
    1) Alcohol ter-butilico
    2) Alcool butylique tertiaire
    3) Butanol tertiaire
    4) 2-Methyl-2-propanol
    5) Trimethyl carbinol
    6) Molecular Formula: C4-H10-O
    7) CAS 75-65-0
    2-Ethylhexyl alcohol
    1) 2-Ethyl-1-hexanol
    2) Molecular Formula: C8-H18-O
    3) CAS 104-76-7
    Isobutylmethylcarbinol
    1) MIC
    2) Methyl isobutyl carbinol
    3) Molecular Formula: C6-H14-O
    4) CAS 108-11-2

Available Forms Sources

    A) FORMS
    1) Higher alcohols with 3, 4, and 5 carbons are available in pure form for laboratory use. They may exist as solids or liquids. The most common of the higher alcohols, 1-pentanol (amyl alcohol), is a colorless liquid with a pleasant odor (Harbison, 1998).
    B) USES
    1) Some are major ingredients in lacquer thinners, paint strippers, and solvents (Clayton & Clayton, 1982). 1-Pentanol is used an an industrial solvent and is also a synthetic flavoring agent (Harbison, 1998).
    2) n-Butanol and 2 methyl-2-butanol (amylene hydrate) have been used as sedatives in human therapy (Gosselin et al, 1984).
    3) In the production of wines and whiskeys, several of these compounds are formed and, when separated by distillation, are referred to as fusel oil (Budavari, 1996).
    4) AMYL ALCOHOLS are used in the manufacture of lacquers, chemicals, plastics, rubber, fruit essences, and explosives. They are intermediates of ore-flotation agents and other amyl derivatives. They are used as an ingredient of paint stripper and hydraulic fluid. ISOAMYL ALCOHOL is used in the preparation of isoamyl derivatives and pharmaceuticals (Clayton & Clayton, 1982).
    5) BUTANOL and its isomers are used as solvents in paints, lacquers, coatings, and resins, as extractants in the manufacture of pharmaceuticals (antibiotics, hormones, and vitamins), and as chemical intermediates (Clayton & Clayton, 1982).
    6) 2-ETHYLHEXYL ALCOHOL is an intermediate in the manufacture of plastics. It is also used as a wetting and dispersing agent, as a solvent for gums and resins, and a cosolvent for nitrocellulose. It is used in ceramics, rubber latex, textiles, and paper coatings (Clayton & Clayton, 1982).
    7) 1-PROPANOL - Used as a solvent, in personal products (eg; hand disinfectant, antiseptic formulations), and household products including window cleaning, and polishing products (Vujasinovic et al, 2007).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: Higher alcohols are alcohols that contain more than 2 carbons, including 1-pentanol (amyl alcohol), used as an industrial solvent and synthetic flavoring agent. N-butanol and 2-methyl-2-butanol (amylene hydrate) have been used as human sedatives. Other higher alcohols are major ingredients in lacquer thinners, paint strippers, and solvents. Other industrial uses for higher alcohols include the manufacture of lacquers, chemicals, plastics, rubber, fruit essences, explosives, hydraulic fluid, pharmaceuticals, ceramics, textiles, disinfectants, and cleaning products.
    B) TOXICOLOGY: Butanols and amyl alcohols (pentanols) are irritants to the eyes, mucous membranes, lungs and GI. Severity of gastric irritation correlates with lipid solubility. Higher alcohols are of a low order of toxicity in an industrial setting. As the carbon chain lengthens, the toxicity decreases. They are not able to penetrate skin as readily as smaller molecular weight alcohols and are less likely to be absorbed by inhalation. The exact mechanism is unknown.
    C) EPIDEMIOLOGY: Products containing higher alcohols are widely available but not many exposures are reported to poison centers with patients presenting with severe effects being very rare.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: Can cause gastrointestinal symptoms such as nausea, vomiting, abdominal cramps and diarrhea. Irritation of mucous membranes may also occur. Dermatitis of varying severity can happen with chronic exposure. Neurologic symptoms include headache, dizziness, giddiness, ataxia and sedation. Vapors from higher alcohols are irritating to the conjunctiva leading to burning, lacrimation, photophobia, corneal disturbances, and vision blurring.
    2) SEVERE TOXICITY: Can cause hypotension and cardiac dysrhythmias, and if aspirated, a hemorrhagic pneumonitis. With severe respiratory exposures, pulmonary edema can occur. Severe ingestions can cause gastrointestinal hemorrhage and liver injury. Finally, hypoglycemia can occur after exposure. After exposure to n-butanol vapor in combination with other solvents, there have been reports of formation of vacuoles in the cornea.
    0.2.20) REPRODUCTIVE
    A) Increased incidence of stillbirth and reduced weight gain in newborns were observed in experimental laboratory female mice given tert-butyl alcohol. Only slight teratogenicity in an inhalation teratology study of 3 butanol isomers.

Laboratory Monitoring

    A) Specific concentrations of alcohols are not clinically useful.
    B) Monitor vital signs and mental status.
    C) In symptomatic patients monitor blood glucose, serum electrolytes, renal function and liver enzymes.
    D) Monitor ECG in symptomatic patients.
    E) In patients with intentional overdoses, obtain acetaminophen and salicylate concentrations.
    F) Patients with respiratory symptoms require a chest x-ray.

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) The mainstay of management of mild to moderate toxicity is removal/decontamination and supportive care. Gastrointestinal symptoms can be treated with antiemetics and fluid hydration.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) For severe toxicity, treatment should be targeted towards symptoms. Hypotensive patients should be given boluses of isotonic fluids and pressors as necessary. Patients with severe respiratory symptoms may required intubation, and if acute lung injury develops, ventilation with small tidal volumes (6 mL/kg). Antibiotics should only be given when there is evidence of infection. Hemodialysis should be performed in patients with severe toxicity not responding to supportive care.
    C) DECONTAMINATION
    1) PREHOSPITAL: GI decontamination is not indicated. Remove contaminated clothing and wash exposed skin with soap and water. Irrigate exposed eyes.
    2) HOSPITAL: GI decontamination is not indicated. Orogastric aspiration can be considered for large or massive ingestions that have occurred recently. Remove contaminated clothing and wash exposed skin with soap and water. Irrigate exposed eyes.
    D) ANTIDOTE
    1) None.
    E) ENHANCED ELIMINATION PROCEDURE
    1) Severely toxic patients (eg, patients with coma, severe metabolic acidosis) may benefit from hemodialysis to remove unmetabolized alcohols or toxic metabolites.
    F) PATIENT DISPOSITION
    1) HOME CRITERIA: Older children or adults with small unintentional ingestions with minimal to no symptoms may be managed at home.
    2) OBSERVATION CRITERIA: Patients should be sent to a healthcare facility if their exposure to higher alcohols was in a self-harm attempt, involved a large volume or if they are symptomatic. They should be observed for 4 to 6 hours and be clearly improving or asymptomatic prior to discharge. In young children, minimal exposures can be symptomatic so any such exposures should be sent in for observation and lab work.
    3) ADMISSION CRITERIA: Patients with severe symptoms or those getting worse after an observation period of 4 to 6 hours should be admitted to the hospital. Depending on the severity of their symptoms, ICU admission may be warranted (eg, intubated patients). Patients should not be discharged until they are clearly improving or asymptomatic.
    4) CONSULT CRITERIA: Consultation with critical care specialists may be required for patients in the ICU. Nephrologists may be needed for consultation for potential dialysis. Consult a clinical toxicologist or poison center for patients with large ingestions, severe symptoms or if the diagnosis is unclear.
    G) PITFALLS
    1) Potential errors in management include confusing higher alcohols with other alcohols and not recognizing the potential for severe symptoms.
    H) TOXICOKINETICS
    1) As with other alcohols, absorption from the gastrointestinal tract appears to be rapid and efficient. Dermal penetration of higher alcohols does not occur as readily as with smaller molecular weight alcohols. Absorption from inhalation is limited and higher chain alcohols are less likely to be inhaled. Primary alcohols are metabolized by alcohol dehydrogenase to corresponding aldehydes and then by aldehyde dehydrogenase to acids. Secondary and tertiary alcohols are eliminated by conjugation with glucuronides. Overall elimination is slower and effects are therefore prolonged. If ketones are formed as metabolites, they may act as sedatives. Many high alcohols and their metabolites are excreted in the urine though some can be excreted in the lungs and feces. Higher alcohols are not bound by proteins and administration of other alcohols may affect metabolism kinetics.
    I) PREDISPOSING CONDITIONS
    1) Patients at extremes of age may be more sensitive to symptoms. Patients with liver and renal disease may be more sensitive to toxicity as well.
    J) DIFFERENTIAL DIAGNOSIS
    1) Ingestion of other alcohols may have some similar features, and ingestion of other substances that can cause CNS depression could be initially confused for ingestion of higher alcohols.
    0.4.3) INHALATION EXPOSURE
    A) SUMMARY: For inhalational exposures, remove the patient to fresh air and give supplemental oxygen and assisted ventilation as needed. If bronchospasm develops, treat with inhaled beta adrenergic agonists.
    B) ACUTE LUNG INJURY: Maintain ventilation and oxygenation and evaluate with frequent arterial blood gases and/or pulse oximetry monitoring. Early use of PEEP and mechanical ventilation may be needed.
    0.4.4) EYE EXPOSURE
    A) Remove contact lenses and irrigate eyes with water for at least 15 minutes.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) Remove contaminated clothing and wash exposed areas thoroughly with soap and water.

Range Of Toxicity

    A) TOXICITY: Minimal lethal or toxic doses are not well established. Ingestion of about 30 mL of tertiary amyl alcohol was fatal in an adult. Another adult died following an enema of 35 grams of tertiary amyl alcohol. An adult who drank 27 g of tertiary amyl alcohol developed coma, dyspnea, irregular pulse, and recovered. An adult developed a mixed acidosis with elevated anion gap but recovered after ingesting an estimated 130 mL of 1-propanol and 300 mL of 2-propranol.

Summary Of Exposure

    A) USES: Higher alcohols are alcohols that contain more than 2 carbons, including 1-pentanol (amyl alcohol), used as an industrial solvent and synthetic flavoring agent. N-butanol and 2-methyl-2-butanol (amylene hydrate) have been used as human sedatives. Other higher alcohols are major ingredients in lacquer thinners, paint strippers, and solvents. Other industrial uses for higher alcohols include the manufacture of lacquers, chemicals, plastics, rubber, fruit essences, explosives, hydraulic fluid, pharmaceuticals, ceramics, textiles, disinfectants, and cleaning products.
    B) TOXICOLOGY: Butanols and amyl alcohols (pentanols) are irritants to the eyes, mucous membranes, lungs and GI. Severity of gastric irritation correlates with lipid solubility. Higher alcohols are of a low order of toxicity in an industrial setting. As the carbon chain lengthens, the toxicity decreases. They are not able to penetrate skin as readily as smaller molecular weight alcohols and are less likely to be absorbed by inhalation. The exact mechanism is unknown.
    C) EPIDEMIOLOGY: Products containing higher alcohols are widely available but not many exposures are reported to poison centers with patients presenting with severe effects being very rare.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: Can cause gastrointestinal symptoms such as nausea, vomiting, abdominal cramps and diarrhea. Irritation of mucous membranes may also occur. Dermatitis of varying severity can happen with chronic exposure. Neurologic symptoms include headache, dizziness, giddiness, ataxia and sedation. Vapors from higher alcohols are irritating to the conjunctiva leading to burning, lacrimation, photophobia, corneal disturbances, and vision blurring.
    2) SEVERE TOXICITY: Can cause hypotension and cardiac dysrhythmias, and if aspirated, a hemorrhagic pneumonitis. With severe respiratory exposures, pulmonary edema can occur. Severe ingestions can cause gastrointestinal hemorrhage and liver injury. Finally, hypoglycemia can occur after exposure. After exposure to n-butanol vapor in combination with other solvents, there have been reports of formation of vacuoles in the cornea.

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) EYE IRRITATION: Vapor of butanols and amyl alcohols are irritating to the conjunctiva leading to burning, lacrimation, photophobia, corneal disturbances and blurring of vision (HSDB , 2001; Harbison, 1998; Grant & Schuman, 1993; Clayton & Clayton, 1982). No permanent ocular damage has been reported.
    a) Irritation of the human eye has been reported at the following concentrations for the listed alcohols: Amyl alcohols (isoamyl alcohol): concentration 150 ppm: butyl alcohol: concentration 50 ppm (RTECS , 2001).
    2) VACUOLAR KERATOPATHY: The formation of vacuoles in the cornea has been reported after exposure to n-butanol vapor in combination with other solvents (Cogan & Grant, 1945; Herman & Hickman, 1948; Jaeger, 1955).
    3) IRITIS has been reported following severe exposures to 1-pentanol (amyl alcohol) (HSDB , 2001).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) HYPOTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) Hypotension may occur following exposure (HSDB , 2001; Bunc et al, 2006).
    B) TACHYCARDIA
    1) WITH POISONING/EXPOSURE
    a) TERT-AMYL ALCOHOL: CASE REPORT: A 28-year-old man was found comatose after ingesting an unknown amount of tert-amyl alcohol. An empty 250-mL plastic bottle of tert-amyl alcohol 99% pure was found in his house. On presentation, he had clinical signs of respiratory failure, unresponsive narrow pupils, tachycardia (up to 150 beats/min), and hypertension (up to 175/95 mmHg). He was intubated and treated with supportive care for 24 hours, but later developed psychomotor agitation after extubation, requiring intensive pharmacological sedation and immobilization. Following the restoration of consciousness, he developed dizziness, headache, drowsiness, nausea, and ataxia, but all symptoms gradually resolved within the next 48 hours. Tert-amyl alcohol blood concentrations on day 1 and 2 of hospitalization were 83 mcg/mL and 19 mcg/mL, respectively. A urine tert-amyl alcohol concentration was 28 mcg/mL on day 2 (Anand et al, 2014).
    C) HYPERTENSIVE DISORDER
    1) WITH POISONING/EXPOSURE
    a) TERT-AMYL ALCOHOL: CASE REPORT: A 28-year-old man was found comatose after ingesting an unknown amount of tert-amyl alcohol. An empty 250-mL plastic bottle of tert-amyl alcohol 99% pure was found in his house. On presentation, he had clinical signs of respiratory failure, unresponsive narrow pupils, tachycardia (up to 150 beats/min), and hypertension (up to 175/95 mmHg). He was intubated and treated with supportive care for 24 hours, but later developed psychomotor agitation after extubation, requiring intensive pharmacological sedation and immobilization. Following the restoration of consciousness, he developed dizziness, headache, drowsiness, nausea, and ataxia, but all symptoms gradually resolved within the next 48 hours. Tert-amyl alcohol blood concentrations on day 1 and 2 of hospitalization were 83 mcg/mL and 19 mcg/mL, respectively. A urine tert-amyl alcohol concentration was 28 mcg/mL on day 2 (Anand et al, 2014).
    D) CONDUCTION DISORDER OF THE HEART
    1) WITH POISONING/EXPOSURE
    a) Cardiac dysrhythmias may occur, with potential cardiac failure, following significant exposure, although this is rare (HSDB , 2001; Gosselin et al, 1984).
    3.5.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) HYPOTENSION
    a) RABBITS - Waugh (1992) reports some hypotension in rabbits treated with warm 7% butyl alcohol vapor for arterial hypoxemia in induced pulmonary edema (Waugh, 1992).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) IRRITATION SYMPTOM
    1) WITH POISONING/EXPOSURE
    a) Inhalation of high concentrations may produce irritation of the respiratory tract. Cough and dyspnea may result from exposures (HSDB , 2001; Harbison, 1998; Clayton & Clayton, 1982).
    B) ACUTE LUNG INJURY
    1) WITH POISONING/EXPOSURE
    a) Pulmonary edema may occur as a result of the irritation or respiratory depression by inhalation (HSDB , 2001; Gosselin et al, 1984).
    C) ACUTE RESPIRATORY INSUFFICIENCY
    1) WITH POISONING/EXPOSURE
    a) 1-PROPANOL: Respiratory depression has been reported in patients with 1-propanol poisoning (Vujasinovic et al, 2007).
    1) COMBINED INGESTION OF 1-PROPRANOL AND 2-PROPANOL: After ingesting an estimated 130 mL of 1-propanol and 300 mL of 2-propanol (Monopronto Extra solution 500 mL bottle; 27.6% of 1-propanol and 36.1% of 2-propanol) found in a hospital hand disinfectant, a 37-year-old man presented to the ED with a Glasgow coma scale of 3, temperature 36.4 degrees C, pulse 110 beats/min, blood pressure 130/80 mm Hg, and respiratory rate of 10/minute. Initial, pulse oximetry was 88% on room air. Physical examination revealed miosis, divergent ocular gaze, absent corneal reflex, hypotonic muscles, absent myotatic and plantar reflexes, and no focal neurological signs. Laboratory findings included metabolic acidosis (pH 7.29; bicarbonate 22.8 mmol/L, pCO2 6.1 kPa, and pO2 12 kPa while receiving 60% oxygen). He began to respond to painful stimuli 4 hours after admission and was fully conscious 2 hours later; he was extubated 12 hours after admission. At this time, the native urine examination revealed increased ketone levels (highest level occurred 14 hours after admission). With supportive therapy, he recovered completely and was discharged on the 3rd day after psychiatric evaluation (Vujasinovic et al, 2007).
    b) TERT-AMYL ALCOHOL: CASE REPORT: A 28-year-old man was found comatose after ingesting an unknown amount of tert-amyl alcohol. An empty 250-mL plastic bottle of tert-amyl alcohol 99% pure was found in his house. On presentation, he had clinical signs of respiratory failure, unresponsive narrow pupils, tachycardia (up to 150 beats/min), and hypertension (up to 175/95 mmHg). He was intubated and treated with supportive care for 24 hours, but later developed psychomotor agitation after extubation, requiring intensive pharmacological sedation and immobilization. Following the restoration of consciousness, he developed dizziness, headache, drowsiness, nausea, and ataxia, but all symptoms gradually resolved within the next 48 hours. Tert-amyl alcohol blood concentrations on day 1 and 2 of hospitalization were 83 mcg/mL and 19 mcg/mL, respectively. A urine tert-amyl alcohol concentration was 28 mcg/mL on day 2 (Anand et al, 2014).
    c) Severe respiratory depression or death has not been reported with any of these compounds by inhalation. In very severe exposures, respiratory depression due to CNS depression could potentially result in death (HSDB , 2001), but this would be very rare.
    d) CASE REPORT: A 47-year-old man with no previous medical history was found comatose and soiled after having vomited while unconscious. He presented to the ED with a Glasgow Coma Scale score of 3, tachycardia (110 BPM), hypotension (systolic blood pressure 70 mmHg), shallow tachypneic breathing (36/min), hypotonic muscles, absent myotatic and plantar reflexes, and an aromatic odor. He was intubated and treated with dopamine, volume replacement, and oxygen. He was lavaged and given activated charcoal. Laboratory findings included acidosis with elevated lactate, renal insufficiency, hypokalemia, and hypercapnic respiratory insufficiency. He began to respond to painful stimuli 12 hours after admission, was fully conscious at 16 hours and was extubated 23 hours after admission. Toxicological examination of urine and gastric content by gas chromatography revealed 1-butanol. With supportive therapy, he had a complete recovery at 30 hours(Bunc et al, 2006).
    3.6.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) HYPOVENTILATION
    a) MICE: Concentrations of n-butanol vapor above 3000 ppm by inhalation in mice produced a decrease in respiratory rate (Kristiansen et al, 1988). Inhalation of n-pentanol, n-heptanol, sec-butanol and tert-pentanol produced decreased respirations in mice (Hansen & Nielsen, 1994).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) CENTRAL NERVOUS SYSTEM DEFICIT
    1) WITH POISONING/EXPOSURE
    a) CNS effects following oral ingestion or inhalation of high concentrations include headache, double vision, deafness, dizziness, giddiness, ataxia, delirium, sedation, respiratory depression, and coma (HSDB , 2001; Harbison, 1998; Arena & Drew, 1986).
    b) TERT-AMYL ALCOHOL: CASE REPORT: A 28-year-old man was found comatose after ingesting an unknown amount of tert-amyl alcohol. An empty 250-mL plastic bottle of tert-amyl alcohol 99% pure was found in his house. On presentation, he had clinical signs of respiratory failure, unresponsive narrow pupils, tachycardia (up to 150 beats/min), and hypertension (up to 175/95 mmHg). He was intubated and treated with supportive care for 24 hours, but later developed psychomotor agitation after extubation, requiring intensive pharmacological sedation and immobilization. Following the restoration of consciousness, he developed dizziness, headache, drowsiness, nausea, and ataxia, but all symptoms gradually resolved within the next 48 hours. Tert-amyl alcohol blood concentrations on day 1 and 2 of hospitalization were 83 mcg/mL and 19 mcg/mL, respectively. A urine tert-amyl alcohol concentration was 28 mcg/mL on day 2 (Anand et al, 2014).
    c) CASE REPORT: A 47-year-old man with no previous medical history was found comatose and soiled after having vomited while unconscious. He presented to the ED with a Glasgow Coma Scale score of 3, tachycardia (110 BPM), hypotension (systolic blood pressure 70 mmHg), shallow tachypneic breathing (36/min), hypotonic muscles, absent myotatic and plantar reflexes, and an aromatic odor. He was intubated and treated with dopamine, volume replacement, and oxygen. He was lavaged and given activated charcoal. Laboratory findings included acidosis with elevated lactate, renal insufficiency, hypokalemia, and hypercapnic respiratory insufficiency. He began to respond to painful stimuli 12 hours after admission, was fully conscious at 16 hours and was extubated 23 hours after admission. Toxicological examination of urine and gastric content by gas chromatography revealed 1-butanol. With supportive therapy, he had a complete recovery at 30 hours (Bunc et al, 2006).
    d) 1-PROPANOL: Somnolence and coma have been reported following an acute 1-propanol ingestion (Vujasinovic et al, 2007).
    1) COMBINED INGESTION OF 1-PROPRANOL AND 2-PROPANOL: After ingesting an estimated 130 mL of 1-propanol and 300 mL of 2-propanol (Monopronto Extra solution 500 mL bottle; 27.6% of 1-propanol and 36.1% of 2-propanol) found in a hospital hand disinfectant, a 37-year-old man presented to the ED with a Glasgow coma scale of 3, temperature 36.4 degrees C, pulse 110 beat/min, blood pressure 130/80 mm Hg, and respiratory rate of 10/minute. Initial, pulse oximetry was 88% on room air. Physical examination revealed miosis, divergent ocular gaze, absent corneal reflex, hypotonic muscles, absent myotatic and plantar reflexes, and no focal neurological signs. Laboratory findings included metabolic acidosis. He began to respond to painful stimuli 4 hours after admission and was fully conscious 2 hours later; he was extubated 12 hours after admission. At this time, the native urine examination revealed increased ketone levels (highest level occurred 14 hours after admission). With supportive therapy, he recovered completely and was discharged on the 3rd day after psychiatric evaluation (Vujasinovic et al, 2007).
    3.7.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) ATAXIA
    a) RATS/MICE: Rats and mice fed 0.25 to 4% w/v t-butyl alcohol experienced ataxia and hypoactivity, which were the earliest clinical signs of toxicity. A statistically significant depression in body weight was present, especially at the higher concentrations, in both mice and rats (Lindamood et al, 1992).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) GASTROINTESTINAL IRRITATION
    1) WITH POISONING/EXPOSURE
    a) Gastrointestinal irritation with nausea, vomiting, and diarrhea are common with an odor of alcohol present in the vomitus and feces if orally ingested (HSDB , 2001; Gosselin et al, 1984).
    b) 1-PROPANOL: Nausea, vomiting, abdominal cramps, diarrhea, and irritation of mucous membranes have been reported following an acute 1-propanol ingestion (Vujasinovic et al, 2007).
    c) TERT-AMYL ALCOHOL: Nausea has been reported following the ingestion of tert-amyl alcohol (Anand et al, 2014).
    B) GASTROENTERITIS
    1) WITH POISONING/EXPOSURE
    a) Nausea, vomiting and diarrhea may occur (HSDB , 2001; Arena & Drew, 1986).
    C) GASTROINTESTINAL HEMORRHAGE
    1) WITH POISONING/EXPOSURE
    a) Gastrointestinal hemorrhage may rarely occur (HSDB , 2001; Weisbrodt et al, 1973).

Hepatic

    3.9.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) HEPATOCELLULAR DAMAGE
    a) Damage to the liver is reported in animals but remains controversial after both acute and chronic toxicity (HSDB , 2001; Gosselin et al, 1984).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) MYOGLOBINURIA
    1) WITH POISONING/EXPOSURE
    a) Myoglobinuria has been reported, but is probably uncommon (Arena & Drew, 1986). Gosselin et al (1984) suggest that myoglobinuria does not usually occur (Gosselin et al, 1984).
    B) GLYCOSURIA
    1) WITH POISONING/EXPOSURE
    a) Glucosuria has been reported following exposure to 2-ethyl-1-hexanol (HSDB , 2001; Arena & Drew, 1986); there remains skepticism of the exact cause of this effect.
    C) RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Renal insufficiency has been reported in a case of 1-butanol poisoning (Bunc et al, 2006).
    3.10.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) RENAL FUNCTION ABNORMAL
    a) RATS: Oral feedings in water, ranging from 0.25 to 4% w/v for 90 days, of t-butyl alcohol resulted in decreased urine volume with crystalluria, urinary tract calculi, renal pelvic and ureteral dilatation, and thickening of the urinary bladder mucosa. Renal changes were more notable in male rats, and toxicity results indicated the urinary tract as the target organ for t-butyl alcohol toxicity (Lindamood et al, 1992).

Acid-Base

    3.11.2) CLINICAL EFFECTS
    A) ACIDOSIS
    1) WITH POISONING/EXPOSURE
    a) Primary alcohols are metabolized to corresponding aldehydes and acids. Accumulation of the acid metabolites is rare but may result in metabolic acidosis (Gosselin et al, 1984).
    b) Acidosis with elevated lactate has been reported in a case of 1-butanol poisoning (Bunc et al, 2006).
    c) 1-PROPANOL: Metabolic acidosis with elevated anion gap have been reported following 1-propanol poisoning. In contrast, patients with 2-propanol poisoning present with ketosis and ketonuria without acidosis 3 to 4 hours after ingestion. In one case report, a patient with a combined ingestion of 1-propranol and 2-propanol presented early with mixed acidosis and elevated anion gap and later with ketosis and ketonuria (12 hours after admission). Refer to "Isopropyl alcohol" management for more information on 2-propanol.
    1) COMBINED INGESTION OF 1-PROPRANOL AND 2-PROPANOL: After ingesting an estimated 130 mL of 1-propanol and 300 mL of 2-propanol (Monopronto Extra solution 500 mL bottle; 27.6% of 1-propanol and 36.1% of 2-propanol) found in a hospital hand disinfectant, a 37-year-old man presented to the ED with a Glasgow coma scale of 3, temperature 36.4 degrees C, pulse 110 beats/min, blood pressure 130/80 mm Hg, and respiratory rate of 10/minute. Initial, pulse oximetry was 88% on room air. Laboratory findings included metabolic acidosis (pH 7.29; bicarbonate 22.8 mmol/L, pCO2 6.1 kPa, and pO2 12 kPa while receiving 60% oxygen). He began to respond to painful stimuli 4 hours after admission and was fully conscious 2 hours later; he was extubated 12 hours after admission. At this time, the native urine examination revealed increased ketone levels (highest level occurred 14 hours after admission). With supportive therapy, he recovered completely and was discharged on the 3rd day after psychiatric evaluation (Vujasinovic et al, 2007).
    3.11.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) ACIDOSIS
    a) RABBITS - 7% warm n-butyl alcohol vapors, used to treat arterial hypoxemia in induced pulmonary edema in rabbits, caused a slight metabolic acidosis which developed slowly (Waugh, 1992; Waugh, 1993).

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) METHEMOGLOBINEMIA
    1) WITH POISONING/EXPOSURE
    a) Methemoglobinemia has rarely been reported from exposure to amyl alcohols (Clayton & Clayton, 1982; Arena & Drew, 1986). These reviews quote a 1903 article in which methemoglobinuria is reported. No evidence of methemoglobinemia is reported, nor is it likely that these alcohols could oxidize the iron of hemoglobin. Myoglobin may have been the compound found in the urine of the case in question, as may be seen after ethanol ingestion.

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) DERMATITIS
    1) WITH POISONING/EXPOSURE
    a) Dermatitis of varying severity may occur (Gosselin et al, 1984), especially following chronic or repeated exposures (Harbison, 1998). Chronic dermal exposure can lead to drying and fissuring.
    1) CASE REPORT: A 58-year-old man developed allergic contact dermatitis associated with use of a sunscreen. The patient was patch tested using the individual components supplied by the manufacturer. The test was positive at the site that corresponded to SD-40 alcohol. He was patch tested again using components of SD-40 alcohol, only the site of the tertiary butyl alcohol showed erythema at 72 hours (Edwards & Edwards, 1982).
    B) ERUPTION
    1) WITH POISONING/EXPOSURE
    a) Cutaneous erythema may occur in susceptible individuals following exposure to straight chain aliphatic alcohols (primary alcohols) (Wilkin & Stewart, 1987).

Endocrine

    3.16.2) CLINICAL EFFECTS
    A) HYPOGLYCEMIA
    1) WITH POISONING/EXPOSURE
    a) Hypoglycemia may occur following exposure.

Reproductive

    3.20.1) SUMMARY
    A) Increased incidence of stillbirth and reduced weight gain in newborns were observed in experimental laboratory female mice given tert-butyl alcohol. Only slight teratogenicity in an inhalation teratology study of 3 butanol isomers.
    3.20.2) TERATOGENICITY
    A) CONGENITAL ANOMALY
    1) tert-BUTYL ALCOHOL: Increased incidence of stillbirth and reduced weight gain in newborns were observed in experimental laboratory female mice given 103 g/kg orally on days 6 to 20 after conception (RTECS , 2001).
    a) Daniel & Evans (1982) concluded that t-butanol was approximately 5 times more potent than ethanol in producing a developmental delay in postnatal physiological and psychomotor performance in mice (Daniel & Evans, 1982).
    b) Nelson et al (1989a) found only slight teratogenicity in an inhalation teratology study of 3 butanol isomers. Concentrations were such that there was evidence of both maternal toxicity (reduced food intake and weight gain) and fetotoxicity (increased variation in weights and reduced weights) (Nelson et al, 1989a).
    c) NEGATIVE effect reported in neonatal rats following maternal inhalation exposure of 3000 and 6000 ppm administered 7 hours/day for 6 weeks throughout gestation and following paternal exposure for 7 hours/day for 6 weeks (Nelson et al, 1989b).
    2) 3-METHYL-1-BUTANOL: Prenatal inhalation of 10 mg/L for 6 hr per day produced no embryo-fetotoxicity or teratogenicity in the fetuses of either rats or rabbits. The no-observable-adverse-effect level (NOAEL) for the dams of both species was determined to be 2.5 mg/L. At the higher concentrations of 10 mg/L a slight decrease in body weight gain in the dams of both species was observed (Klimisch & Hellwig, 1995).
    3) 2-ETHYLHEXYL ALCOHOL: Musculoskeletal and urogenital abnormalities were noted in offspring of experimental laboratory female mice given 16 mg/kg orally for 12 days after conception (RTECS , 2001).
    4) 1-PROPANOL: NEGATIVE effect reported in neonatal rats following maternal inhalation exposure of 3,500 and 7,000 ppm administered 7 hours/day for 6 weeks throughout gestation and following paternal exposure for 7 hours/day for 6 weeks (Nelson et al, 1989c).
    5) 2-METHYL-1-PROPANOL: Prenatal inhalation of 10 mg/L for 6 hr per day produced no embryo-fetotoxicity or teratogenicity in the fetuses of either rats or rabbits (Klimisch & Hellwig, 1995).
    3.20.4) EFFECTS DURING BREAST-FEEDING
    A) BREAST MILK
    1) BUTYL ALCOHOL: Grant & Samson (1982) noted that microcephaly was apparent in rats administered t-butanol in milk on postnatal days 4 to 7. Blood t-butanol concentration in the rats was approximately 250 mg/100 mL (Grant & Samson, 1982).

Carcinogenicity

    3.21.4) ANIMAL STUDIES
    A) CARCINOMA
    1) ISOAMYL ALCOHOL - POSITIVE for liver tumors and leukemia in rats at 27 g/kg orally intermittently for 75 weeks (RTECS , 2001).
    a) POSITIVE for liver tumors and leukemia in rats at 3,800 mg/kg subcutaneously intermittently for 85 weeks (RTECS , 2001).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Specific concentrations of alcohols are not clinically useful.
    B) Monitor vital signs and mental status.
    C) In symptomatic patients monitor blood glucose, serum electrolytes, renal function and liver enzymes.
    D) Monitor ECG in symptomatic patients.
    E) In patients with intentional overdoses, obtain acetaminophen and salicylate concentrations.
    F) Patients with respiratory symptoms require a chest x-ray.

Radiographic Studies

    A) CHEST RADIOGRAPH
    1) Monitor chest x-ray in symptomatic patients following significant inhalation exposure.

Methods

    A) CHROMATOGRAPHY
    1) Blood levels should be determined by gas liquid chromatography for accurate identification of the alcohol.
    2) Gas chromatography-mass spectrometry (GC-MS) was used to obtain blood concentrations of tert-amyl alcohol in a 28-year-old man who developed coma and respiratory failure after ingesting an unknown amount of tert-amyl alcohol. Tert-amyl alcohol blood concentrations on day 1 and 2 of hospitalization were 83 mcg/mL and 19 mcg/mL, respectively. A urine tert-amyl alcohol concentration was 28 mcg/mL on the day 2 (Anand et al, 2014).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) Patients with severe symptoms or those getting worse after an observation period of 4 to 6 hours should be admitted to the hospital. Depending on the severity of their symptoms, ICU admission may be warranted (eg, intubated patients). Patients should not be discharged until they are clearly improving or asymptomatic.
    6.3.1.2) HOME CRITERIA/ORAL
    A) Older children or adults with small unintentional ingestions with minimal to no symptoms may be managed at home.
    6.3.1.3) CONSULT CRITERIA/ORAL
    A) Consultation with critical care specialists may be required for patients in the ICU. Nephrologists may be needed for consultation for potential dialysis. Consult a clinical toxicologist or poison center for patients with large ingestions, severe symptoms or if the diagnosis is unclear.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) Patients should be sent to a healthcare facility if their exposure to higher alcohols was in a self-harm attempt, involved a large volume or if they are symptomatic. They should be observed for 4 to 6 hours and be clearly improving or asymptomatic prior to discharge. In young children, minimal exposures can be symptomatic so any such exposures should be sent in for observation and lab work.

Monitoring

    A) Specific concentrations of alcohols are not clinically useful.
    B) Monitor vital signs and mental status.
    C) In symptomatic patients monitor blood glucose, serum electrolytes, renal function and liver enzymes.
    D) Monitor ECG in symptomatic patients.
    E) In patients with intentional overdoses, obtain acetaminophen and salicylate concentrations.
    F) Patients with respiratory symptoms require a chest x-ray.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) PREHOSPITAL: GI decontamination is not indicated. Remove contaminated clothing and wash exposed skin with soap and water. Irrigate exposed eyes.
    6.5.2) PREVENTION OF ABSORPTION
    A) GI decontamination is not indicated. Orogastric aspiration can be considered for large or massive ingestions that have occurred recently. Remove contaminated clothing and wash exposed skin with soap and water. Irrigate exposed eyes.
    6.5.3) TREATMENT
    A) MONITORING OF PATIENT
    1) Specific concentrations of alcohols are not clinically useful.
    2) Monitor vital signs and mental status.
    3) In symptomatic patients monitor blood glucose, serum electrolytes, renal function and liver enzymes.
    4) Monitor ECG in symptomatic patients.
    5) In patients with intentional overdoses, obtain acetaminophen and salicylate concentrations.
    6) Patients with respiratory symptoms require a chest x-ray.
    B) HYPOTENSIVE EPISODE
    1) SUMMARY
    a) Infuse 10 to 20 milliliters/kilogram of isotonic fluid and keep the patient supine. If hypotension persists, administer dopamine or norepinephrine. Consider central venous pressure monitoring to guide further fluid therapy.
    2) DOPAMINE
    a) DOSE: Begin at 5 micrograms per kilogram per minute progressing in 5 micrograms per kilogram per minute increments as needed (Prod Info dopamine hcl, 5% dextrose IV injection, 2004). If hypotension persists, dopamine may need to be discontinued and a more potent vasoconstrictor (eg, norepinephrine) should be considered (Prod Info dopamine hcl, 5% dextrose IV injection, 2004).
    b) CAUTION: If ventricular dysrhythmias occur, decrease rate of administration (Prod Info dopamine hcl, 5% dextrose IV injection, 2004). Extravasation may cause local tissue necrosis, administration through a central venous catheter is preferred (Prod Info dopamine hcl, 5% dextrose IV injection, 2004).
    3) NOREPINEPHRINE
    a) PREPARATION: 4 milligrams (1 amp) added to 1000 milliliters of diluent provides a concentration of 4 micrograms/milliliter of norepinephrine base. Norepinephrine bitartrate should be mixed in dextrose solutions (dextrose 5% in water, dextrose 5% in saline) since dextrose-containing solutions protect against excessive oxidation and subsequent potency loss. Administration in saline alone is not recommended (Prod Info norepinephrine bitartrate injection, 2005).
    b) DOSE
    1) ADULT: Dose range: 0.1 to 0.5 microgram/kilogram/minute (eg, 70 kg adult 7 to 35 mcg/min); titrate to maintain adequate blood pressure (Peberdy et al, 2010).
    2) CHILD: Dose range: 0.1 to 2 micrograms/kilogram/minute; titrate to maintain adequate blood pressure (Kleinman et al, 2010).
    3) CAUTION: Extravasation may cause local tissue ischemia, administration by central venous catheter is advised (Peberdy et al, 2010).
    C) ACUTE LUNG INJURY
    1) ONSET: Onset of acute lung injury after toxic exposure may be delayed up to 24 to 72 hours after exposure in some cases.
    2) NON-PHARMACOLOGIC TREATMENT: The treatment of acute lung injury is primarily supportive (Cataletto, 2012). Maintain adequate ventilation and oxygenation with frequent monitoring of arterial blood gases and/or pulse oximetry. If a high FIO2 is required to maintain adequate oxygenation, mechanical ventilation and positive-end-expiratory pressure (PEEP) may be required; ventilation with small tidal volumes (6 mL/kg) is preferred if ARDS develops (Haas, 2011; Stolbach & Hoffman, 2011).
    a) To minimize barotrauma and other complications, use the lowest amount of PEEP possible while maintaining adequate oxygenation. Use of smaller tidal volumes (6 mL/kg) and lower plateau pressures (30 cm water or less) has been associated with decreased mortality and more rapid weaning from mechanical ventilation in patients with ARDS (Brower et al, 2000). More treatment information may be obtained from ARDS Clinical Network website, NIH NHLBI ARDS Clinical Network Mechanical Ventilation Protocol Summary, http://www.ardsnet.org/node/77791 (NHLBI ARDS Network, 2008)
    3) FLUIDS: Crystalloid solutions must be administered judiciously. Pulmonary artery monitoring may help. In general the pulmonary artery wedge pressure should be kept relatively low while still maintaining adequate cardiac output, blood pressure and urine output (Stolbach & Hoffman, 2011).
    4) ANTIBIOTICS: Indicated only when there is evidence of infection (Artigas et al, 1998).
    5) EXPERIMENTAL THERAPY: Partial liquid ventilation has shown promise in preliminary studies (Kollef & Schuster, 1995).
    6) CALFACTANT: In a multicenter, randomized, blinded trial, endotracheal instillation of 2 doses of 80 mL/m(2) calfactant (35 mg/mL of phospholipid suspension in saline) in infants, children, and adolescents with acute lung injury resulted in acute improvement in oxygenation and lower mortality; however, no significant decrease in the course of respiratory failure measured by duration of ventilator therapy, intensive care unit, or hospital stay was noted. Adverse effects (transient hypoxia and hypotension) were more frequent in calfactant patients, but these effects were mild and did not require withdrawal from the study (Wilson et al, 2005).
    7) However, in a multicenter, randomized, controlled, and masked trial, endotracheal instillation of up to 3 doses of calfactant (30 mg) in adults only with acute lung injury/ARDS due to direct lung injury was not associated with improved oxygenation and longer term benefits compared to the placebo group. It was also associated with significant increases in hypoxia and hypotension (Willson et al, 2015).

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) For inhalational exposures, remove the patient to fresh air and give supplemental oxygen and assisted ventilation as needed. If bronchospasm develops, treat with inhaled beta adrenergic agonists.
    6.7.2) TREATMENT
    A) ACUTE LUNG INJURY
    1) ONSET: Onset of acute lung injury after toxic exposure may be delayed up to 24 to 72 hours after exposure in some cases.
    2) NON-PHARMACOLOGIC TREATMENT: The treatment of acute lung injury is primarily supportive (Cataletto, 2012). Maintain adequate ventilation and oxygenation with frequent monitoring of arterial blood gases and/or pulse oximetry. If a high FIO2 is required to maintain adequate oxygenation, mechanical ventilation and positive-end-expiratory pressure (PEEP) may be required; ventilation with small tidal volumes (6 mL/kg) is preferred if ARDS develops (Haas, 2011; Stolbach & Hoffman, 2011).
    a) To minimize barotrauma and other complications, use the lowest amount of PEEP possible while maintaining adequate oxygenation. Use of smaller tidal volumes (6 mL/kg) and lower plateau pressures (30 cm water or less) has been associated with decreased mortality and more rapid weaning from mechanical ventilation in patients with ARDS (Brower et al, 2000). More treatment information may be obtained from ARDS Clinical Network website, NIH NHLBI ARDS Clinical Network Mechanical Ventilation Protocol Summary, http://www.ardsnet.org/node/77791 (NHLBI ARDS Network, 2008)
    3) FLUIDS: Crystalloid solutions must be administered judiciously. Pulmonary artery monitoring may help. In general the pulmonary artery wedge pressure should be kept relatively low while still maintaining adequate cardiac output, blood pressure and urine output (Stolbach & Hoffman, 2011).
    4) ANTIBIOTICS: Indicated only when there is evidence of infection (Artigas et al, 1998).
    5) EXPERIMENTAL THERAPY: Partial liquid ventilation has shown promise in preliminary studies (Kollef & Schuster, 1995).
    6) CALFACTANT: In a multicenter, randomized, blinded trial, endotracheal instillation of 2 doses of 80 mL/m(2) calfactant (35 mg/mL of phospholipid suspension in saline) in infants, children, and adolescents with acute lung injury resulted in acute improvement in oxygenation and lower mortality; however, no significant decrease in the course of respiratory failure measured by duration of ventilator therapy, intensive care unit, or hospital stay was noted. Adverse effects (transient hypoxia and hypotension) were more frequent in calfactant patients, but these effects were mild and did not require withdrawal from the study (Wilson et al, 2005).
    7) However, in a multicenter, randomized, controlled, and masked trial, endotracheal instillation of up to 3 doses of calfactant (30 mg) in adults only with acute lung injury/ARDS due to direct lung injury was not associated with improved oxygenation and longer term benefits compared to the placebo group. It was also associated with significant increases in hypoxia and hypotension (Willson et al, 2015).
    B) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) Remove contact lenses and irrigate eyes with water for at least 15 minutes.

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) Remove contaminated clothing and wash exposed areas thoroughly with soap and water.

Enhanced Elimination

    A) HEMODIALYSIS
    1) Severely toxic patients (eg, patients with coma, severe metabolic acidosis) may benefit from hemodialysis to remove unmetabolized alcohols or toxic metabolites.
    2) Hemodialysis may remove unmetabolized alcohol or its toxic metabolites in patients with deep and persistent coma (Wallgren, 1960).

Summary

    A) TOXICITY: Minimal lethal or toxic doses are not well established. Ingestion of about 30 mL of tertiary amyl alcohol was fatal in an adult. Another adult died following an enema of 35 grams of tertiary amyl alcohol. An adult who drank 27 g of tertiary amyl alcohol developed coma, dyspnea, irregular pulse, and recovered. An adult developed a mixed acidosis with elevated anion gap but recovered after ingesting an estimated 130 mL of 1-propanol and 300 mL of 2-propranol.

Minimum Lethal Exposure

    A) SPECIFIC SUBSTANCE
    1) AMYL ALCOHOL
    a) 30 mL of tertiary amyl alcohol was fatal in a case involving an adult human (Gosselin et al, 1984).
    b) Aspiration of 0.2 mL of n-amyl alcohol produced instant death in 10 out of 10 rats (Clayton & Clayton, 1982).
    c) There is a report of a patient who died following an enema of 35 grams of tert-AMYL ALCOHOL (Clayton & Clayton, 1982).
    2) BUTYL ALCOHOL
    a) Estimate of single oral mean fatal dose of any butanol taken from rat data is 3 to 7 ounces in man (Gosselin et al, 1984).
    3) PROPYL ALCOHOL
    a) Ingestion of 20 mL of 1-propanol diluted with water caused feeling of warmth and lowering of blood pressure.

Maximum Tolerated Exposure

    A) SPECIFIC SUBSTANCE
    1) AMYL ALCOHOL
    a) CASE REPORT: One patient intentionally drank 27 grams of tert-AMYL ALCOHOL and developed coma, dyspnea, irregular pulse, and dilation of pupils initially, followed by contraction of pupils (Clayton & Clayton, 1982).
    b) TERT-AMYL ALCOHOL: CASE REPORT: A 28-year-old man was found comatose after ingesting an unknown amount of tert-amyl alcohol. An empty 250-mL plastic bottle of tert-amyl alcohol 99% pure was found in the house. On presentation, he had clinical signs of respiratory failure, unresponsive narrow pupils, tachycardia (up to 150 beats/min), and hypertension (up to 175/95 mmHg). He was intubated and treated with supportive care for 24 hours, but later developed psychomotor agitation after extubation, requiring intensive pharmacological sedation and immobilization. Following the restoration of consciousness, he developed dizziness, headache, drowsiness, nausea, and ataxia, but all symptoms gradually resolved within the next 48 hours. Tert-amyl alcohol blood concentrations on day 1 and 2 of hospitalization were 83 mcg/mL and 19 mcg/mL, respectively. A urine tert-amyl alcohol concentration was 28 mcg/mL on day 2 (Anand et al, 2014).
    2) BUTYL ALCOHOL
    a) There have been no reports of systemic toxicity in humans from sec-BUTYL ALCOHOL. It is irritating and excessive exposure may result in mucous membrane irritation, nausea, fatigue, and dizziness (Clayton & Clayton, 1982).
    b) No systemic toxicity has been reported in humans from tert-BUTYL ALCOHOL. It may be a skin irritant; slight erythema and hyperemia have been reported after application to human skin. Excessive exposure may produce nausea, fatigue, dizziness, and irritation of the eye, nose, and throat (Clayton & Clayton, 1982).
    c) 2-ETHYLHEXYL ALCOHOL: Is used in large quantities in industry (for many years) without reports of human toxicity (Clayton & Clayton, 1982).
    3) 1-PROPANOL
    a) CASE REPORT: A 37-year-old man developed mixed acidosis with elevated anion gap after ingesting an estimated 130 mL of 1-propanol and 300 mL of 2-propanol (Monopronto Extra solution 500 mL bottle; 27.6% of 1-propanol and 36.1% of 2-propanol) found in a hospital hand disinfectant. He also experienced ketosis with ketonuria 12 hours after admission. With supportive therapy, he recovered completely and was discharged on the 3rd day after psychiatric evaluation (Vujasinovic et al, 2007).
    B) ANIMAL DATA
    1) The extrapolated threshold concentration for nasal irritation of n-pentanol, n-heptanol, sec-butanol, and tert-pentanol in mice, as measured by decreased respiratory rate, were 120, 28, 640, and 1210 ppm, respectively, for a two-minute exposure (Hansen & Nielsen, 1994).

Serum Plasma Blood Concentrations

    7.5.2) TOXIC CONCENTRATIONS
    A) TOXIC CONCENTRATION LEVELS
    1) TERT-AMYL ALCOHOL: CASE REPORT: A 28-year-old man developed coma and respiratory failure after ingesting an unknown amount of tert-amyl alcohol. An empty 250-mL plastic bottle of tert-amyl alcohol 99% pure was found in his house. Tert-amyl alcohol blood concentrations on day 1 and 2 of hospitalization were 83 mcg/mL and 19 mcg/mL, respectively. A urine tert-amyl alcohol concentration was 28 mcg/mL on day 2 (Anand et al, 2014).

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) LD50- (ORAL)RAT:
    1) 1.87 mg/kg (Vujasinovic et al, 2007)
    B) LD50- (ORAL)MOUSE:
    1) 200 mg/kg (RTECS , 2001a)
    C) LD50- (INTRAPERITONEAL)RAT:
    1) 579 mg/kg (RTECS , 2001a)
    D) LD50- (ORAL)RAT:
    1) 2200 mg/kg (RTECS , 2001a)
    E) LD50- (ORAL)RAT:
    1) 1000 mg/kg (RTECS , 2001a)
    F) LD50- (INTRAPERITONEAL)RAT:
    1) 1122 mg/kg (RTECS , 2001a)
    G) LD50- (ORAL)RAT:
    1) 790 mg/kg (RTECS , 2001a)
    H) LD50- (INTRAPERITONEAL)RAT:
    1) 1193 mg/kg (RTECS , 2001a)
    I) LD50- (ORAL)RAT:
    1) 6480 mg/kg (RTECS , 2001a)
    J) LD50- (INTRAPERITONEAL)MOUSE:
    1) 933 mg/kg (RTECS , 2001a)
    K) LD50- (ORAL)RAT:
    1) 3500 mg/kg (RTECS , 2001a)
    L) 2-ETHYL HEXYL ALCOHOL
    1) LD50- (ORAL)MOUSE:
    a) 2500 mg/kg (RTECS , 2001a)
    2) LD50- (INTRAPERITONEAL)RAT:
    a) 500 mg/kg (RTECS , 2001a)
    3) LD50- (ORAL)RAT:
    a) 2049 mg/kg (RTECS , 2001a)
    4) LD50- (SUBCUTANEOUS)RAT:
    a) 650 mg/kg (RTECS , 2001a)
    M) 3-PENTANOL
    1) LD50- (ORAL)RAT:
    a) 1870 mg/kg (RTECS , 2001a)
    N) ISOAMYL ALCOHOL
    1) LD50- (ORAL)RAT:
    a) 1300 mg/kg (RTECS , 2001a)
    2) TCLo- (INHALATION)HUMAN:
    a) 150 ppm (RTECS , 2001a)

Pharmacologic Mechanism

    A) Alcohols are primarily CNS depressants. Amyl alcohols have been reported to have a transient CNS stimulant effect, but this appears early after poisoning and is superseded by the depressant action. Tolerance occurs on repeated exposure. In their sedative properties, higher alcohols are up to 5 times more potent than ethanol although n-propanol appears approximately equipotent with ethanol.

Toxicologic Mechanism

    A) IRRITATION
    1) Butanols and amyl alcohols (pentanols) are irritants to eyes and mucous membranes and skin. In the lungs, the irritant properties lead to a hemorrhagic pneumonitis and this effect has been reported in animals after ingestion.
    2) Gastrointestinal hemorrhage, along with vomiting and diarrhea may occur. Damage to the gastric mucosa is best correlated with the lipid solubility of the alcohol. The higher the lipid solubility, the greater the effect of the compound on altering the electrical potential changes across the mucosa. This appears to correlate with gastric irritation.
    B) METHEMOGLOBINEMIA: Several reviews report that methemoglobinemia may occur. These authors quote a 1903 article in which methemoglobinuria is reported. No evidence of methemoglobinemia is reported, nor is it likely that these alcohols could oxidize the iron of hemoglobin. Myoglobinuria may have been the compound found in the urine of the case in question, as may be seen after ethanol ingestion.
    C) HEPTOTOXICITY/RENAL TOXICITY
    1) Damage to the liver and kidneys is not conclusive, but suggests that evidence of hepatic and renal damage should be sought.
    2) Male rats exposed to t-butyl alcohol in drinking water at concentrations of 0.25 to 4% w/v experienced microscopic renal changes. An exacerbation of nephropathy, most likely due to the accumulation of a-2micro-globulin in the kidney, was observed. The amount and duration of a-2micro-globulin deposition in the kidneys appears to be a determinant in causing enhanced cell proliferation in the kidney (Lindamood et al, 1992).

Physical Characteristics

    A) ISOAMYL ALCOHOL: Liquid with characteristic, disagreeable odor and pungent, repulsive taste (Budavari, 1996)
    B) dl-sec-ISOAMYL ALCOHOL: Liquid (Budavari, 1996)
    C) n-AMYL ALCOHOL: Liquid with characteristic, pleasant odor (Harbison, 1998; Budavari, 1996)
    D) dl-sec-AMYL ALCOHOL: Liquid with characteristic odor (Budavari, 1996)
    E) 3-PENTANOL: Liquid with characteristic odor (Budavari, 1996)
    F) tert-AMYL ALCOHOL: Volatile liquid with characteristic sour odor and burning taste (Budavari, 1996; Clayton & Clayton, 1982)
    G) n-BUTYL ALCOHOL: Highly refractive liquid with fusel oil type odor that is irritating (Budavari, 1996)
    H) sec-BUTYL ALCOHOL: Liquid (Budavari, 1996)
    I) tert-BUTYL ALCOHOL: Crystals with camphor-like odor (Budavari, 1996)
    J) 2-ETHYLHEXYL ALCOHOL: Colorless liquid (Budavari, 1996)

Molecular Weight

    A) varies

General Bibliography

    1) Anand JS, Gieron J, Lechowicz W, et al: Acute intoxication due to tert-amyl alcohol--a case report. Forensic Sci Int 2014; 242:e31-e33.
    2) Arena JM & Drew RH: Poisoning: Toxicology, Symptoms, Treatments, 5th ed, Charles C Thomas, Springfield, IL, 1986.
    3) Artigas A, Bernard GR, Carlet J, et al: The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling.. Am J Respir Crit Care Med 1998; 157:1332-1347.
    4) Brower RG, Matthay AM, & Morris A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342:1301-1308.
    5) Budavari S: The Merck Index, 12th ed, Merck & Co, Inc, Whitehouse Station, NJ, 1996.
    6) Bunc M, Pezdir T, Mozina H, et al: Butanol ingestion in an airport hangar. Hum Exp Toxicol 2006; 25(4):195-197.
    7) Cataletto M: Respiratory Distress Syndrome, Acute(ARDS). In: Domino FJ, ed. The 5-Minute Clinical Consult 2012, 20th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2012.
    8) Clayton GD & Clayton FE: Patty's Industrial Hygiene and Toxicology, Vol 2C. Toxicology, 3rd ed, John Wiley & Sons, New York, NY, 1982.
    9) Cogan DG & Grant WM: An unusual type of Keratitis associated with exposure to n-butyl alcohol (butanol). Arch Ophthalmol 1945; 35:106-109.
    10) Daniel MA & Evans MA: Quantitative comparison of maternal ethanol and maternal tertiary butanol diet on postnatal development. J Pharmacol Exp Ther 1982; 222:294-300.
    11) Edwards EK Jr & Edwards EK: Allergic reaction to tertiary butyl alcohol in a sunscreen. Cutis 1982; 29:476-478.
    12) Gosselin RE, Smith RP, & Hodge HC: Clinical Toxicology of Commercial Products, 5th ed, Williams & Wilkins, Baltimore, MD, 1984.
    13) Grant LA & Samson HH: Ethanol and tertiary butanol induced microcephaly in the neonatal rat: comparison of brain growth parameters. Neurobehavioral Toxicol Teratol 1982; 4:315-321.
    14) Grant WM & Schuman RS: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993.
    15) HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    16) Haas CF: Mechanical ventilation with lung protective strategies: what works?. Crit Care Clin 2011; 27(3):469-486.
    17) Hansen LF & Nielsen GD: Sensory irritation, pulmonary irritation and structure- activity relationships of alcohols. Toxicology 1994; 88(1-3):81-99.
    18) Harbison RD: Hamilton & Hardy's Industrial Toxicology, 5th edition, Mosby, St Louis, MO, 1998.
    19) Herman H & Hickman FH: The adhesion of epithelium to stroma. Bull Johns Hopkins Hosp 1948; 82:182-207.
    20) Jaeger W: Injury to the cornea to butyl alcohol. Graefes Arch Ophthalmol 1955; 156:480-483.
    21) Kleinman ME, Chameides L, Schexnayder SM, et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 14: pediatric advanced life support. Circulation 2010; 122(18 Suppl.3):S876-S908.
    22) Klimisch HJ & Hellwig J: Studies on the prenatal toxicity of 3-methyl-1- butanol and 2-methyl-1-propanol in rats and rabbits following inhalation exposure. Fundam Appl Toxicol 1995; 27:77-89.
    23) Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37.
    24) Kristiansen U, Vinggaard AM, & Nielsen GD: The effects of n-butanol vapour on respiratory rate and tidal volume. Arch Toxicol 1988; 61:229-236.
    25) Lindamood C, Farnell DR, & Giles HD: Subchronic toxicity studies of t-butyl alcohol in rats and mice. Fundam Appl Toxicol 1992; 19:91-100.
    26) NHLBI ARDS Network: Mechanical ventilation protocol summary. Massachusetts General Hospital. Boston, MA. 2008. Available from URL: http://www.ardsnet.org/system/files/6mlcardsmall_2008update_final_JULY2008.pdf. As accessed 2013-08-07.
    27) Nelson BK, Brightwell WS, & Khan A: Lack of selective developmental toxicity of three butanol isomers administered by inhalation to rats. Fundam Appl Toxicol 1989a; 12:469-479.
    28) Nelson BK, Brightwell WS, & Robertson SK: Behavioral teratology investigation of 1-Butanol in rats. Neurotoxicol Teratol 1989b; 11:313-315.
    29) Nelson BK, Brightwell WS, & Taylor BJ: Behavioral teratology investigation of 1-propanol administered by inhalation to rats. Neurotoxicol Teratol 1989c; 11:153-159.
    30) Peberdy MA , Callaway CW , Neumar RW , et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care science. Part 9: post–cardiac arrest care. Circulation 2010; 122(18 Suppl 3):S768-S786.
    31) Product Information: dopamine hcl, 5% dextrose IV injection, dopamine hcl, 5% dextrose IV injection. Hospira,Inc, Lake Forest, IL, 2004.
    32) Product Information: norepinephrine bitartrate injection, norepinephrine bitartrate injection. Sicor Pharmaceuticals,Inc, Irvine, CA, 2005.
    33) RTECS : Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    34) RTECS : Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires July/31/2001a; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    35) Stolbach A & Hoffman RS: Respiratory Principles. In: Nelson LS, Hoffman RS, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies, 9th ed. McGraw Hill Medical, New York, NY, 2011.
    36) Vujasinovic M, Kocar M, Kramer K, et al: Poisoning with 1-propanol and 2-propanol. Hum Exp Toxicol 2007; 26(12):975-978.
    37) Wallgren H: Relative intoxicating effects on rats of ethyl, propyl and butyl alcohols. Acta Pharmacol Toxicol 1960; 16:217-222.
    38) Waugh WH: Adjuvant use of warm butyl alcohol vapor in experimental pulmonary edema. Life Sciences 1992; 52:171-182.
    39) Waugh WH: Potential use of warm butyl alcohol vapor as adjunct agent in the emergency treatment of sea water wet near-drowning. Am J Emerg Med 1993; 11:20-27.
    40) Weisbrodt NW, Kienzle M, & Cooke AR: Comparative effects of aliphatic alcohols on the gastric mucosa. Proc Soc Exp Biol Med 1973; 142:450-454.
    41) Wilkin JK & Stewart JH: Substrate specificity of human cutaneous alcohol dehydrogenase and erythema provoked by lower aliphatic alcohols. J Invest Dermatol 1987; 88:452-454.
    42) Willson DF, Truwit JD, Conaway MR, et al: The adult calfactant in acute respiratory distress syndrome (CARDS) trial. Chest 2015; 148(2):356-364.
    43) Wilson DF, Thomas NJ, Markovitz BP, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005; 293:470-476.